Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) reported $52.44 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 25.3%. EPS of -$ 0.20 for the same period compares to - $0.33 a year ago.The reported revenue compares to the Zacks Consensus Estimate of$ 43.15 million, representing a surprise of +21.53%. The company delivered an EPS surprise of +28.57%, with the consensus EPS estimate being -$0.28.While investors closely watch year-over-year changes in headline numbers -- revenue an ...